The American Innovation Engine: Keeping the United States Competitive for Biopharmaceutical Investors

The Importance of Investment

Today, there are 7,000 new medications being developed by biopharmaceutical companies around the globe. Investors look many factors when deciding to fund this research, including market size, demand, and the local policy environment. Data shows that countries that offer protection of intellectual property (IP) rights, as well as those with inclusive R&D policies, are most likely to benefit from the billions of dollars invested annually into the biopharmaceutical industry. In addition to fueling treatments and cures, a supportive policy environment keeps the United States competitive for investors, both foreign and domestic.

The Impact of Investment

The impact of biopharmaceutical investment is not just measured by improved health care and quality of life for patients. We can also see the direct, measurable impact by studying a nation’s economy and the development of its workforce.

For America, this economic impact is massive. The U.S. biopharmaceutical sector employs more than 803,000 workers, ultimately supporting millions of jobs across the country. This impact would not be possible without the investment obtained through our competitive culture of innovation and IP protection.

Analyzing investment across countries shows that while the US is highly competitive, we may face challenges in certain regulatory areas. Remaining a leader in the global market for biopharmaceutical investment is key to continued job creation and economic strength.

Read the comparative analysis of 15 countries here.